Natco Pharma informs about Press Release

19 Jun 2015 Evaluate

Natco Pharma has informed about a Press Release dated June 19, 2015 titled ‘US Court of Appeals for the Federal Circuit Finds TevaS 808 COPAXONE Patent Invalid’.

The above information is a part of company’s filings submitted to BSE.

Natco Pharma Share Price

1019.35 18.65 (1.86%)
06-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1798.95
Dr. Reddys Lab 1303.90
Cipla 1321.75
Zydus Lifesciences 912.95
Lupin 2344.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×